All News

The development of biologics started with diphtheria- history of Medicine! Look how far we have come now prescribing over 50 different types of biologics! @RheumNow #acr20 https://t.co/XbygK5g7ON

BKZ tx improved BASDAI total and single question scores related to fatigue and neck, back and hip pain in pts with PsA. #ABS0906 #ACR20 @RheumNow https://t.co/GzpJfkwvL5 https://t.co/KnJAqAKlqq

Bimekizumab Treatment Is Associated with Improvements in Back Pain and Fatigue …

Do pts with RA take their meds & can adherence intervention work? Yes & No. Pts starting new bDMARD RCT of electronic monitoring feedback vs usual care, adherence>80%. Neg RCT Maybe chronic users with poor adherence is group to study abstr#0799 #ACR2020 @RheumNow https://t.co/FyWoBjYnvs

Valerio et al find 40% of 294 patients w/ #rheumaticdisease refuse or are uncertain about getting inactivated #influenza #vaccine. Key determinants of #vaccinehesitancy found to be concerns about adverse events, safety & efficacy. Abs#0632 #ACR20 @RheumNow https://t.co/f34DAc5WiN

Systems Approach to Understanding Reasons for Influenza Vaccine Hesitancy in Rh…

Do you consistently address T2T in your axSpA patients in your clinical practice? List your measures below! #ACR20 @RheumNow

Which Adalimumab biosimilar to use (if any)? The race is on to have 1st Ada or 2nd reimbursed/preferentially listed in US reimbursement plans & dare I say it mandatory switching like in Europe. Abstr#0798 #ACR2020 compares Abrilada & Humira in RA @RheumNow @CRASCRRheum https://t.co/AUcVZnc6Gj

In the search for biomarkers in PsA, interesting study showing absolute lymphocyte count is negatively correlated with cardiovascular disease risk score and red cell distribution width and increases with TNF-Inhibitor Therapy @rheumnow #ACR20 Abstr#878

Some great abstracts on #vaccine hesitancy in the #infection in #rheumaticdiseases poster session! What's the greatest concern for patients offered #influenza & #pneumococcal vaccines? How can we address these concerns & encourage vaccine uptake? Comment below! #ACR20 @RheumNow

T2T in clinical practice: Most axSpA pts had ≥1 annual ASDAS recorded, but target ID/LDA achieved in only 1/3 of pts at the first measurement. How do you address T2T in your practice? #ABS0879 #ACR20 @RheumNow https://t.co/Jy0mmqpHAb https://t.co/06fI10V3OZ

Application of Treat-to-Target in Axial Spondyloarthritis in Daily Practice - A…

Great job by @Rheumnow's Dr. Jonathan Kay on CT-P17, ADA biosimilar in Abst#0800. Similar ACR20 83% rate for ADA and CT-P17 with similar safety profile. #ACR20.

Lots at #ACR20 on arthralgias w/ +CCP. Abst#760 shows bone erosions (BE) rare in these pts (4%), did not show higher risk of progression to IA (41% w BE vs 31% wo BE, p=0.4). Overall high progression, unclear if high enough # with BE for analysis. @RheumNow.

Tracking CRP in the hyper-acute phase of admission for #COVID19 predictive of progression to critical illness- suggests trends of inflammatory biomarkers, not absolute admission values, may be most useful for triage & therapy. Abs#0626 #ACR20 @RheumNow https://t.co/E14y3e4ALi

Early Rise in CRP Is Associated with Progression to Respiratory Failure and Int…

Dr. J. Walsh slide on PROs in PsA research. #ACR20 ⁦@RheumNow⁩ https://t.co/v4ufUdWufB

RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by Novartis. All content chosen by @RheumNow and its Faculty.

What is your initial csDMARD of choice in pts w/ elderly-onset RA? @RheumNow #ACR20

Baseline characteristics differed between M/F pts w/ AS & nr-axSpA. Women were older at dz onset w/longer symptom duration & more joint dz and were less likely to be + HLA-B27 than men. Do you see this in your practice? #ABS0876 #ACR20 @RheumNow https://t.co/2goek1NiUW https://t.co/Uk8pmNP4Hr

Gender Differences in Baseline Clinical Characteristics Among Patients with Ank…

Patients with ARDs have incr. susceptibility to #infection. Real-world study shows suboptimal #influenza, #pneumococcal & #herpeszoster #vaccination coverage in these patients. Important to consider strategies to improve uptake. Abs#0541 #ACR20 @RheumNow https://t.co/GAapkzILvW

Suboptimal Vaccination Coverage with Influenza, Pneumococcal and Herpes Zoster …

Dr Peral reports on intracellular crystal containing vacuoles in gout and CPP arthritis. Crystal containing vacuoles only seen in CPP arthritis. @rheumnow #ACR20 Abstr#666 https://t.co/ITQMXhjQt0

Serial RF titers? Abst#0754 from Japan: Pts with RF>45, tracked RF at month 0/4/12 after starting b/tsDMARD. 46/130 had RF decrease titers, had better radiographic remission/DAS28-ESR. Limits: varied Rx, More aggressive Rx w RF decrease grp @RheumNow. #ACR20

Dr Vargas-Santos reported on risk of gout with SGLT2-inhibitors using THIN database. Canagliflozin shown in prior RCT to reduce gout risk. Here dapagliflozin and empagliflozin showed even stronger effect @rheumnow #ACR20 Abstr#660 https://t.co/MTjByMmHo7

Topics

All News

Do you get our email newsletter?